Literature DB >> 34060004

The parkinsonian LRRK2 R1441G mutation shows macroautophagy-mitophagy dysregulation concomitant with endoplasmic reticulum stress.

Sokhna M S Yakhine-Diop1,2,3, Mario Rodríguez-Arribas1,2,3, Saray Canales-Cortés1, Guadalupe Martínez-Chacón1,2,3, Elisabet Uribe-Carretero1,2,3, Mercedes Blanco-Benítez1, Gema Duque-González1, Marta Paredes-Barquero1, Eva Alegre-Cortés1, Vicente Climent4, Ana Aiastui5,6, Adolfo López de Munain2,7,8,9, José M Bravo-San Pedro2,10, Mireia Niso-Santano11,12,13, José M Fuentes14,15,16, Rosa A González-Polo17,18,19.   

Abstract

Autophagy is a mechanism responsible for the degradation of cellular components to maintain their homeostasis. However, autophagy is commonly altered and compromised in several diseases, including neurodegenerative disorders. Parkinson's disease (PD) can be considered a multifactorial disease because environmental factors, genetic factors, and aging are involved. Several genes are involved in PD pathology, among which the LRRK2 gene and its mutations, inherited in an autosomal dominant manner, are responsible for most genetic PD cases. The R1441G LRRK2 mutation is, after G2019S, the most important in PD pathogenesis. Our results demonstrate a relationship between the R1441G LRRK2 mutation and a mechanistic dysregulation of autophagy that compromises cell viability. This altered autophagy mechanism is associated with organellar stress including mitochondrial (which induces mitophagy) and endoplasmic reticulum (ER) stress, consistent with the fact that patients with this mutation are more vulnerable to toxins related to PD, such as MPP+.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Autophagy; MAMs; Mitochondrial dysfunction; Neurodegeneration; Parkinson disease

Mesh:

Substances:

Year:  2021        PMID: 34060004     DOI: 10.1007/s10565-021-09617-w

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.819


  77 in total

1.  The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization.

Authors:  Rosa M Canet-Avilés; Mark A Wilson; David W Miller; Rili Ahmad; Chris McLendon; Sourav Bandyopadhyay; Melisa J Baptista; Dagmar Ringe; Gregory A Petsko; Mark R Cookson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-04       Impact factor: 11.205

2.  The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway.

Authors:  José M Bravo-San Pedro; Mireia Niso-Santano; Rubén Gómez-Sánchez; Elisa Pizarro-Estrella; Ana Aiastui-Pujana; Ana Gorostidi; Vicente Climent; Rakel López de Maturana; Rosario Sanchez-Pernaute; Adolfo López de Munain; José M Fuentes; Rosa A González-Polo
Journal:  Cell Mol Life Sci       Date:  2012-07-08       Impact factor: 9.261

3.  LRRK2 impairs PINK1/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson's disease.

Authors:  Fiona Bonello; Sidi-Mohamed Hassoun; François Mouton-Liger; Yea Seul Shin; Adeline Muscat; Christelle Tesson; Suzanne Lesage; Philip M Beart; Alexis Brice; Johannes Krupp; Jean-Christophe Corvol; Olga Corti
Journal:  Hum Mol Genet       Date:  2019-05-15       Impact factor: 6.150

4.  Mutant LRRK2 elicits calcium imbalance and depletion of dendritic mitochondria in neurons.

Authors:  Salvatore J Cherra; Erin Steer; Aaron M Gusdon; Kirill Kiselyov; Charleen T Chu
Journal:  Am J Pathol       Date:  2012-12-08       Impact factor: 4.307

5.  Calcium signaling and neurodegenerative diseases.

Authors:  Ilya Bezprozvanny
Journal:  Trends Mol Med       Date:  2009-02-21       Impact factor: 11.951

6.  Enhanced parkin levels favor ER-mitochondria crosstalk and guarantee Ca(2+) transfer to sustain cell bioenergetics.

Authors:  Tito Calì; Denis Ottolini; Alessandro Negro; Marisa Brini
Journal:  Biochim Biophys Acta       Date:  2013-01-09

Review 7.  Role of Autophagy in Parkinson's Disease.

Authors:  Silvia Cerri; Fabio Blandini
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

8.  Leucine-rich repeat kinase 2 regulates Sec16A at ER exit sites to allow ER-Golgi export.

Authors:  Hyun Jin Cho; Jia Yu; Chengsong Xie; Parvathi Rudrabhatla; Xi Chen; Junbing Wu; Loukia Parisiadou; Guoxiang Liu; Lixin Sun; Bo Ma; Jinhui Ding; Zhihua Liu; Huaibin Cai
Journal:  EMBO J       Date:  2014-09-08       Impact factor: 11.598

Review 9.  Disturbed mitochondrial dynamics and neurodegenerative disorders.

Authors:  Florence Burté; Valerio Carelli; Patrick F Chinnery; Patrick Yu-Wai-Man
Journal:  Nat Rev Neurol       Date:  2014-12-09       Impact factor: 42.937

10.  Parkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and α-Synuclein Accumulation.

Authors:  Sun Young Chung; Sarah Kishinevsky; Joseph R Mazzulli; John Graziotto; Ana Mrejeru; Eugene V Mosharov; Lesly Puspita; Parvin Valiulahi; David Sulzer; Teresa A Milner; Tony Taldone; Dimitri Krainc; Lorenz Studer; Jae-Won Shim
Journal:  Stem Cell Reports       Date:  2016-09-15       Impact factor: 7.765

View more
  4 in total

1.  G2019S LRRK2 Mutation Enhances MPP+-Induced Inflammation of Human Induced Pluripotent Stem Cells-Differentiated Dopaminergic Neurons.

Authors:  Ying Chen; Qing Yin; Xiao-Yu Cheng; Jin-Ru Zhang; Hong Jin; Kai Li; Cheng-Jie Mao; Fen Wang; Hong-Zhe Bei; Chun-Feng Liu
Journal:  Front Neurosci       Date:  2022-07-06       Impact factor: 5.152

Review 2.  Biological effects of olive oil phenolic compounds on mitochondria.

Authors:  Mercedes Blanco-Benítez; Ana Calderón-Fernández; Saray Canales-Cortés; Eva Alegre-Cortés; Elisabet Uribe-Carretero; Marta Paredes-Barquero; Alberto Gimenez-Bejarano; Gema Duque González; Patricia Gómez-Suaga; Juan Ortega-Vidal; Sofía Salido; Joaquín Altarejos; Guadalupe Martínez-Chacón; Mireia Niso-Santano; José M Fuentes; Rosa A González-Polo; Sokhna M S Yakhine-Diop
Journal:  Mol Cell Oncol       Date:  2022-03-20

3.  Delay of EGF-Stimulated EGFR Degradation in Myotonic Dystrophy Type 1 (DM1).

Authors:  Eva Alegre-Cortés; Alberto Giménez-Bejarano; Elisabet Uribe-Carretero; Marta Paredes-Barquero; André R A Marques; Mafalda Lopes-da-Silva; Otília V Vieira; Saray Canales-Cortés; Pedro J Camello; Guadalupe Martínez-Chacón; Ana Aiastui; Roberto Fernández-Torrón; Adolfo López de Munain; Patricia Gomez-Suaga; Mireia Niso-Santano; Rosa A González-Polo; José M Fuentes; Sokhna M S Yakhine-Diop
Journal:  Cells       Date:  2022-09-27       Impact factor: 7.666

Review 4.  Molecular Pathways Involved in LRRK2-Linked Parkinson's Disease: A Systematic Review.

Authors:  Ailyn Irvita Ravinther; Hemaniswarri Dewi Dewadas; Shi Ruo Tong; Chai Nien Foo; Yu-En Lin; Cheng-Ting Chien; Yang Mooi Lim
Journal:  Int J Mol Sci       Date:  2022-10-03       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.